Internal Medicine, Infectious Disease · Dallas, TX
NPI
1083813141
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5939 Harry Hines Blvd
Dallas, TX, 75235
Phone (214) 645-6427
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
296 services
Medicare patients, 2024
157
Average age 70
Drug cost, 2024
$1.3M
1,088 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James B Cutrell was code 99214 (office e&m - established), 74 times for 47 patients. In total James B Cutrell billed 296 services in 12 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 74 | 47 | $93.09 | $6,888 |
| 99232 Hospital E&M - Subsequent | Facility | 64 | 41 | $60.91 | $3,898 |
| 99222 Hospital E&M - Initial | Facility | 50 | 49 | $100.00 | $5,000 |
| 99233 Hospital E&M - Subsequent | Facility | 35 | 16 | $91.37 | $3,198 |
| 99215 Office E&M - Established | Office | 31 | 21 | $132.75 | $4,115 |
| 99204 Office E&M - New | Office | 17 | 17 | $131.13 | $2,229 |
| 99205 Office E&M - New | Office | 11 | 11 | $167.56 | $1,843 |
By year: 2022 $33K for 5,253 services; 2023 $49K for 9,057 services; 2024 $29K for 296 services.
Medicare prescription drug claims, 2024
In 2024, the drug James B Cutrell prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 104 prescriptions and refills. In total James B Cutrell wrote 1,088 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 104 | 104 | 11 | $412K |
| Daptomycin Generic | 93 | 93 | 24 | $60K |
| Ceftriaxone Ceftriaxone Sodium | 63 | 63 | 18 | $3,168 |
| Ertapenem Ertapenem Sodium | 61 | 61 | 15 | $22K |
| Amikacin Sulfate Generic | 50 | 50 | Under 11 | $2,779 |
| Descovy Emtricitabine/Tenofov Alafenam | 49 | 49 | Under 11 | $110K |
| Tigecycline Generic | 44 | 44 | Under 11 | $67K |
| Doxycycline Monohydrate Generic | 41 | 57 | 19 | $1,694 |
| Azithromycin Generic | 37 | 72 | Under 11 | $1,025 |
| Tivicay Dolutegravir Sodium | 32 | 32 | Under 11 | $79K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 30 | 30 | 11 | $6,685 |
| Juluca Dolutegravir/Rilpivirine | 23 | 23 | Under 11 | $83K |
| Darunavir Generic | 20 | 20 | Under 11 | $11K |
| Cefazolin Sodium Generic | 20 | 20 | Under 11 | $1,571 |
| Ritonavir Generic | 20 | 22 | Under 11 | $1,613 |
Brand drugs: 339 claims; generic drugs: 749 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to James B Cutrell were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.